Takaya Shimura

34PUBLICATIONS
81CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyPredictive and prognostic markersTissue engineeringEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Oct 06, 2026
Increased Lymphocyte Proportions as a Candidate Biomarker for Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitors and Chemotherapy.

|Jul 28, 2025
cGAS-STING Pathway Activation Enhances Antitumor Effect of Talaporfin Photodynamic Therapy Through ROS Production.

Makiko Sasaki, Mamoru Tanaka, Yasunari Sasaki

|Jul 23, 2025
Ramucirumab-containing chemotherapy for patients with gastrointestinal neuroendocrine carcinoma refractory/intolerant to platinum-based chemotherapy: A multicenter observational retrospective study (WJOG13420G).

Yuki Matsubara, Toshiki Masuishi, Waki Hosoda

|Jun 12, 2025
Implication of KLHL Gene Family Member KLHL5 in Colorectal Cancer Progression and Prognosis.

Konomu Uno, Hirotada Nishie, Hiromi Hiyoshi

|Apr 29, 2025
Perivascular Niche-Resident Alveolar Macrophages Promote Interstitial Pneumonitis Related to Trastuzumab Deruxtecan Treatment.

Qing Wei, Teng Yang, Ziwen Zhang

|Feb 13, 2025
BRAF V600E and Non-V600E Mutations in RAS Wild-Type Metastatic Colorectal Cancer: Prognostic and Therapeutic Insights from a Nationwide, Multicenter, Observational Study (J-BROS).

Hiroya Taniguchi, Kay Uehara, Toshiaki Ishikawa

Pageof 6

Frequent Collaborators

6 joint publications

Hiromi Kataoka

5 joint publications

Mamoru Tanaka

2 joint publications

Ziwen Zhang

2 joint publications

Takahito Katano